Acurx Pharmaceuticals, Inc.

NASDAQ
ACXP
Stock
Yield per half year: -60.61%
Dividend yield: 0%
Sector: Healthcare

Reporting Acurx Pharmaceuticals, Inc.

Capitalization

2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.0349 0.0415 0.0414 0.0393 5.86
Чистая прибыль, млрд $
-0.0059 -0.0046 -0.0127 -0.0121 -0.0146 -14.1 -14.1 -2.8288 398.07
EV, млрд $
-0.0025 -0.0031 0.0239 0.036 0.0411 0.0095 0.0095 0.0215 -225.10
EBIT, млрд $
-0.0059 -0.0046 -0.0129 -0.0242 -0.0292 -0.0292 -0.0154 37.69
EBITDA, млрд $
-0.0059 -0.0046 -0.0129 -0.0121 -0.0146 -0.0141 -0.0141 -0.0117 25.11
OIBDA, млрд $
-0.0046 -0.013 -0.0121 -0.0146 14.07 14.07 2.81 -597.86
Баланс стоимость, млрд $
0.00082 0.0027 0.0124 0.0073 0.0047 0.6151 0.6151 0.1284 196.15
FCF, млрд $
-0.004 -0.0034 -0.005 -0.0075 -0.0098 -0.0104 -0.0104 -0.0072 25.06
Операционный денежный поток, млрд $
-0.004 -0.0034 -0.005 -0.0075 -0.0098 -0.0104 -0.0104 -0.0072 25.06
Операционная прибыль, млрд $
-0.0059 -0.0046 -0.0129 -0.0121 -0.0146 -0.0141 -0.0141 -0.0117 25.11
Операционные расходы, млрд $
0.0059 0.0046 0.0128 0.0121 0.0146 0.0141 0.0141 0.0116 25.11
CAPEX, млрд $
0


Balance sheet

2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0025 0.0032 0.013 0.0091 0.0075 0.0037 0.0037 0.0073 2.95
Total Receivables $
0.000129 0.0001 0.0001 0.0001 -11.95
Total Current Assets $
0.0025 0.0032 0.0133 0.0094 0.0077 0.0039 0.0039 0.0075 4.04
Активы, млрд $
0.0025 0.0032 0.0133 0.0094 0.0077 0.0039 0.0039 0.0075 4.04
Short Term Debt $
0.0000
Long Term Debt $
0.0001 0.0001 0.00
Задолженность, млрд $
0.0017 0.000522 0.000844 0.0021 0.003 0.0032 0.0032 0.0019 43.71
Чистый долг, млрд $
-0.0025 -0.0031 -0.013 -0.0091 -0.0075 -0.0037 -0.0037 -0.0073 3.60
Долг, млрд $
0.0001 0.0001 0.00
Расходы на обслуживание долга $
0.0001 0 0.0001 0.00
Амортизация, млрд $
0 0 0.0001 0.0121 0.0146 0.0146 0.0089 426.56


Share

2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.7906 -0.4821 -1.49 -1.12 -1.15 -872.54 -872.54 -175.3564 348.26
Цена акции ао 5.01 3.98 3.83 0.814 0.305 0.305 2.79 -42.87
Число акций ао, млн 7.5 9.54 8.54 10.82 12.67 16.16 16.16 11.55 11.12
FCF/акцию -0.5312 -0.3513 -0.5874 -0.6973 -0.7735 -0.6424 -0.6424 -0.6104 12.83


Efficiency

2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -723.45 -261.26 -167.83 -122.6 -243.33 -4550.95 -4550.95 17.60 -1069.1940 77.09
ROA, % -234.3 -159.85 -153.92 -106.86 -170.64 -243848.85 -243848.85 5.71 -48888.0240 333.19
ROS, % 0 0 0 0 13.36
ROCE, % -723.45 -167.19 -104.33 -330.63 -624.76 -4739.81 -4739.81 9.73 -1193.3440 95.21
Ebit margin, % 0 0
Рентаб EBITDA, % 0 0 26.54
Operation Margin, % 0 0 0 0 16.64
Доходность FCF, % -14.36 -18.16 -23.67 -18.7300 18.13


Coefficients

2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-2.75 -3.44 -2.84 64.96 -3.0100 1.08
P/BV
2.97 6.17 10.4 21.39 21.39 8.15 10.23 63.82
P/FCF
-6.96 -5.51 0 0 0 0 8.97 -6.2350 -11.02
E/P
-0.3632 -0.2911 -0.3521 0 0 0 0.03 -0.3355 -1.03
EV/EBIT
0.4187 0.6758 -2.42 -1.49 -1.41 -1.35 -0.3241 -0.3241 -1.3988 -33.11
EV/EBITDA
0.4187 0.6758 -1.86 -2.98 -2.82 -0.6701 -0.6701 51.61 -1.5309 -199.83
EV/S
0 0 0 0 7.82
EV/FCF
0.6231 0.9276 -6.22 -4.77 -4.19 -0.9101 -0.9101 -0.9101 17.75 -3.4000 -31.91
Debt/EBITDA
-0.0145 0 0 0 0 2.58 -0.0145 0.00
Netdebt/Ebitda
0.4187 0.6758 1.01 0.7535 0.5127 0.2628 0.2628 0.2628 0.46 0.5604 -23.61
Debt/Ratio
0.0206 0 0 0 0 0.24 0.0206 0.00
Debt/Equity
0.0246 0 0 5.27 5.27 1.91 2.65 1363.65
Debt/Net Income
-0.0145 0 0 0 0 10.75 -0.0145 0.00
PEG
0 0
Бета
2.34 -4.96 0.0866 0.0866 -0.19 -0.8445 -66.68
Индекс Альтмана
0 -5.19 -5121.75 -5121.75 12.59 -2563.4700 3041.42


Dividends

LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.71


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Other

2023 2024 CAGR 5
Персонал, чел
4 4 0.00